Pharmaceutical Consulting

Navigating pharmaceutical markets across China and the Asia-Pacific region requires more than ambition. With complex regulatory frameworks, evolving pricing systems, and competitive dynamics, companies need more than just local presence, they need a partner with deep industry knowledge, robust strategy, and executional strength.

Cisema offers pharmaceutical consulting services that help companies in the pharmaceutical industry, including biotech, gene therapy, and life sciences innovators, prepare for market entry, accelerate approvals, and optimize commercialization across the region. We support clients with a comprehensive understanding of regulatory pathways, drug development stages, and clinical research demands.

Chinese testing
Pharmaceutical Market Access Consulting
Pharma and Biotech Innovation

Our services include:

Regulatory strategy and planning to reduce risks and eliminate uncertainty
Accelerated registration pathways to shorten time-to-market streamline the drug development process
End-to-end compliance support to meet regional requirements and safeguard operations
Market access strategies tailored to to maximize value, patient reach, and commercial success.

Whether you’re initiating clinical trials, navigating drug registration, or expanding across Asia Pacific, we deliver targeted solutions and proven results across all stages of development.

Work with Cisema to stay ahead of regulatory trends, reduce time-to-market, and achieve sustainable success across China and the broader Asia-Pacific region.

Discover Our Pharmaceutical Consulting Services

Pharmaceutical Development & Strategy

Drive successful market entry and growth with confidence. Our pharmaceutical regulatory consulting experts support biotech and life sciences companies in streamlining drug development, accelerating approvals, and achieving commercialization through tailored strategies, clinical insights, and end-to-end compliance solutions.

Scientific, Technical & Clinical Due Diligence
Development Strategy & Gap Analysis
Regulatory and Clinical Strategy Development
Health Authority Interaction
Scientific, Medical, Technical & Regulatory Writing

Health Economics & Market Access

Accelerate access across China and Asia Pacific with confidence. Our market access consultants help life sciences companies optimize patient access, navigate pricing and reimbursement challenges, and enable commercial success through real world evidence, health economics, and tailored access strategies.

Market Intelligence
Pricing and Reimbursement (P&R) Landscape Analysis
Strategic Market Entry & Pricing Models
Reimbursement Strategy
Competitive Dynamics Assessment
Stakeholder Engagement & Market Insights

Pharmaceutical Regulatory Affairs

Navigate regulatory complexity across China and Asia Pacific with confidence. Our regulatory affairs consulting experts support life sciences clients with strategic planning, compliant submissions, and local representation to accelerate approvals and ensure market readiness.

Scientific, Technical and Regulatory Strategy
Procedure Management
CMC & Compliance
Health Authority Interaction
Labeling Management & Promotional Material Review
Legal Agent / Domestic Responsible Agent

Pharmaceutical Quality Management & Compliance

Ensure regulatory excellence across China and Asia Pacific with confidence. Our quality management and compliance experts help life sciences organizations strengthen GxP systems, streamline audits, and maintain inspection readiness to safeguard market access and operational performance.

Review, Assessment & Pre-audits of GxP/QMS/SOPs
Ingredient Compliance Analysis
Vendor Audit and Management
Pre-approval Inspection
China & overseas factory audits
Official NMPA Inspection Assistance

Pharmacovigilance

Ensure drug safety and regulatory compliance across China and Asia Pacific with confidence. Our pharmacovigilance consulting experts support life sciences companies in managing risks, meeting evolving safety requirements, and maintaining market authorization through end-to-end PV solutions tailored to local regulations.

Signal Management
Risk Management
Case Safety Report Management
Clinical Trial Safety
Pharmacovigilance System Audit & CAPA
Post-Marketing Surveillance

Why Cisema?

Cisema brings together regional expertise, industry insights, and operational excellence to support pharmaceutical success. We work closely with our clients to address regulatory, strategic, and quality challenges, ensuring timely approvals, sustainable market access, and efficient commercialization. Our consultants are trusted by leaders across the life sciences industry for their depth of experience and commitment to quality outcomes.


We help you:

Prepare your product pipeline for China and the Asia Pacific region
Develop effective strategies aligned with local healthcare policy
Respond quickly to evolving trends and regulatory shifts
Navigate compliance requirements with confidence
Optimize clinical trial processes, data use, and real-world evidence

Whether your focus is innovation, access, or long-term growth, our consulting solutions are built to deliver measurable results.

Pharma and healthcare expertise from the Cisema team

Request a Proposal from Our Pharma Team

Let Cisema help turn your plans into reality.

Request Proposal

Useful Articles

View More

Malaysia Drug–Medical Device Combination Products: A Guide to Classification & Regulatory Pathways

Learn how Malaysia classifies drug–medical device combination products and how the PMOA determines pathways and compliance responsibilities.

April 16, 2026
Malaysia Drug–Medical Device Combination Products: A Guide to Classification & Regulatory Pathways
Laboratory professional in protective eyewear, hair cover, sterile gown, and blue nitrile gloves examining a filled syringe in a clean laboratory environment.

China Hyaluronic Acid Registration: A Complete Guide

A complete guide to China hyaluronic acid registration, covering classification, NMPA requirements, and compliance steps for manufacturers.

April 16, 2026
China Hyaluronic Acid Registration: A Complete Guide
China Hyaluronic Acid Registration: A Complete Guide

How Singapore Accelerates ASEAN Market Entry for Medical Devices, Pharma, and Cosmetics

This guide explains Singapore’s HSA regulatory system and why it is a strategic first step for entering Southeast Asian markets with medical devices, pharmaceuticals, and cosmetics.

April 16, 2026
How Singapore Accelerates ASEAN Market Entry for Medical Devices, Pharma, and Cosmetics
Expand into Southeast Asia with Confidence – Singapore as Your Regulatory Gateway

GBA Connect Scheme: Using Real World Data to Support China NMPA Approval

Discover how leveraging Real World Data generated in the Greater Bay Area can accelerate market entry for medical products in China.

April 15, 2026
GBA Connect Scheme: Using Real World Data to Support China NMPA Approval
GBA Connect Scheme: Using Real World Data to Support China NMPA Approval
Previous
Previous

Other Industries We Support

In addition to pharmaceuticals and biotech, we offer consulting services across regulated industries, including medical devices, IVDs, cosmetics, health foods, veterinary products, and other industrial and consumer goods. Our team ensures tailored regulatory compliance strategies, regardless of product category or manufacturing model.

Medical Devices

In-Vitro Diagnostics

Biotech

Cosmetics

Health Foods & Supplements

Veterinary Medicines & Products

Industrial Goods & Consumer Products

How We’ve Helped Clients with Our Expert Guidance

Read about how we work with clients to find solutions, bringing together deep industry knowledge with leading talent.

View More
April 18, 2026

China Manufacture License Renewal for Level A2 Pressure Vessels

Cisema supported Inox Torres Group in successfully renewing its China SELO license for Level A2 pressure vessels through expert audit preparation and regulatory guidance.

Learn More
China Manufacture License Renewal for Level A2 Pressure Vessels
Previous
Previous

Latest Insights

View More

BPOM Clarifies Indonesia–US Trade Agreement Impact on Pharmaceutical Regulation

BPOM confirms pharmaceutical authorization, GMP oversight, and regulatory authority remain unchanged under the Indonesia–US trade agreement.

April 17, 2026
BPOM Clarifies Indonesia–US Trade Agreement Impact on Pharmaceutical Regulation
Laboratory scientist wearing a lab coat, protective goggles, gloves, and a blue hair cover carefully examining a small vial of liquid in a modern laboratory. A tray of sample vials sits on the bench in front.

NMPA CDE Issues MRCT Benefit-Risk Assessment Guideline

China releases guiding principles for benefit-risk assessment using multi-regional clinical trial data to support global drug development.

April 17, 2026
NMPA CDE Issues MRCT Benefit-Risk Assessment Guideline

NMPA Issues Guidance on Subject Selection for Anti-Tumor Drug BE and PK Studies

China releases new subject selection guidance for anti-tumor drug bioequivalence and pharmacokinetic studies.

April 17, 2026
NMPA Issues Guidance on Subject Selection for Anti-Tumor Drug BE and PK Studies

Malaysia Introduces Reliance and Priority Review Mechanisms for Additional Drug Indication Applications

Malaysia’s NPRA introduces reliance and priority review pathways for additional indications of registered innovator drugs.

April 17, 2026
Malaysia Introduces Reliance and Priority Review Mechanisms for Additional Drug Indication Applications

Malaysia Mandates Testing for Diethylene Glycol (DEG) and Ethylene Glycol (EG) in High-Risk Oral Liquid Products

Malaysia’s NPRA mandates DEG and EG testing for high-risk oral liquid products , with mandatory compliance starting April 1, 2027.

April 17, 2026
Malaysia Mandates Testing for Diethylene Glycol (DEG) and Ethylene Glycol (EG) in High-Risk Oral Liquid Products

Vietnam Cuts Advertising Red Tape for Healthcare Products

Vietnam’s MoH recently published Circular drops several healthcare advertising regulations and streamlines requirements for many categories.

April 17, 2026
Vietnam Cuts Advertising Red Tape for Healthcare Products
Previous
Previous

Get in Touch with Our Pharmaceutical Consultants

Speak to our consultants to learn how our comprehensive services, regulatory guidance, and operational expertise can help you stay ahead in the complex pharmaceutical regulatory environment of China and the Asia Pacific region.

Request Proposal